ClinicalTrials.Veeva

Menu

Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care (MADCO-PC)

Duke University logo

Duke University

Status and phase

Completed
Phase 4

Conditions

Alzheimers Disease
Post Operative Cognitive Dysfunction
Postoperative Delirium

Treatments

Drug: General anesthesia with isoflurane
Drug: Total intravenous anesthesia with propofol

Study type

Interventional

Funder types

Other

Identifiers

NCT01993836
Pro00045180

Details and patient eligibility

About

This study will examine the hypothesis that changes in the cognition (i.e. thinking and memory) after anesthesia and surgery are correlated with changes in markers of Alzheimers Disease in the fluid around the brain and spinal cord (i.e. cerebrospinal fluid, or CSF), and/or changes in brain connectivity. The investigators will also examine whether different types of anesthesia have different effects on these CSF markers of Alzheimers disease, or different effects on thinking and memory after anesthesia and surgery, or differential effects on the correlation between cognitive changes and CSF marker changes.

Enrollment

191 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Surgical patients 60 years of age or older
  • Surgery scheduled to last at least 2 hours (including time for anesthesia induction, etc)
  • English speaking ability.
  • Ability to give informed consent

Exclusion criteria

  • Inmate of a correctional facility (i.e. prisoners).
  • Pregnancy
  • Documented or suspected family or personal history of malignant hyperthermia.
  • Patient unable to receive either propofol or isoflurane due to allergy or other specific contraindication.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

191 participants in 2 patient groups

Total Intravenous Anesthesia with Propofol
Active Comparator group
Description:
Patients in this arm will receive general anesthesia with propofol as the primary amnestic agent.
Treatment:
Drug: Total intravenous anesthesia with propofol
General anesthesia with Isoflurane
Active Comparator group
Description:
Patients in this arm will undergo general anesthesia with isoflurane as the primary amnestic agent.
Treatment:
Drug: General anesthesia with isoflurane

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems